Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
Myelodysplastic syndrome (MDS) refers to a heterogeneous group of closely related clonal hematopoietic disorders, which are characterized by accumulation of somatic mutations. The acquired mutation burden is suggested to define the pathway and consequent phenotype of the pathology. Recent studies ha...
Main Authors: | Dmitrii S. Bug, Artem V. Tishkov, Ivan S. Moiseev, Yuri B. Porozov, Natalia V. Petukhova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2357 |
Similar Items
-
Evaluating the Effect of 3′-UTR Variants in <i>DICER1</i> and <i>DROSHA</i> on Their Tissue-Specific Expression by miRNA Target Prediction
by: Dmitrii S. Bug, et al.
Published: (2021-07-01) -
The Drosha rs10719 T>C polymorphism is associated with preeclampsia susceptibility
by: Mahnaz Rezaei, et al.
Published: (2018-07-01) -
Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis
by: I. Ormenezi, et al.
Published: (2022-12-01) -
Expression levels of Drosha and Dicer enzymes and DGCR8 protein in pre-eclamptic patients
by: Roghayeh Dargahi, et al.
Published: (2018-02-01) -
Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells
by: Heike Braun, et al.
Published: (2021-09-01)